Teva Faces Infringement Suits Over TriCor Patent
Brussels-based drug manufacturer Solvay Pharmaceuticals has filed patent infringement lawsuits to stop Teva Pharmaceuticals from selling a generic version of cholesterol drug TriCor – a move that will likely prompt additional...To view the full article, register now.
Already a subscriber? Click here to view full article